This study demonstrated that ARVC clinical phenotypes, recapitulated by a mouse model, (1) were largely preventable before the onset of cardiomyopathy and (2) can be attenuated after the onset of disease by exogenous restoration of PKP2 expression. Here, PKP2 is linked to cardiomyopathy.